Noltrex, 2.5 ml syringe

Noltrex – restores the viscoelastic properties of synovial fluid.

Pharmacodynamics

It helps restore the viscosity of synovial fluid in the joints affected by osteoarthritis.

As a result, it reduces pain and improves joint mobility. A particular feature of the material is its longer duration of action compared to other materials that replenish the viscosity of synovial fluid.

Indications

Treatment of osteoarthritis (osteoarthritis) of all large joints at any stage.

Pharmacological effect

Noltrex – restores the viscoelastic properties of synovial fluid.

Pharmacodynamics

Helps restore the viscosity of synovial fluid in joints affected by osteoarthritis.

As a result, pain decreases and joint mobility improves. A special feature of the material is its long duration of action compared to other materials that replenish the viscosity of synovial fluid.

Special instructions

Noltrex™ is intended only for administration by authorized personnel in accordance with law. The syringe, needle and any unused material must be destroyed immediately after the treatment session in accordance with country law.

If the packaging is damaged, the material should not be used.

Before use, you must carefully read the instructions for use.

The material is intended for single use.

Do not expose the drug to direct sunlight, do not freeze, store at temperatures from +1 to +30 °C.

Repeated sterilization of the material may disrupt the physical state and chemical bonds in the product.

Adverse reactions should be reported to a representative of Bioform Research Center CJSC.

Composition

Active ingredients:

three-dimensional polyacrylamide network polymer (4.5±1.5)%;

purified water (95.5±1.5)%;

silver ions

Contraindications

inflammatory conditions of the skin in the area of ​​intended injection of the material;
injection of material into an infected or inflamed joint;
after arthroscopic operations (within 1 week after the intervention);
introduction of material into glandular tissue;
diabetes is a relative contraindication – taking into account the slight vulnerability of tissues in diabetes, it is necessary to be more careful about the use of the material in this category of patients;
pregnancy and breastfeeding (no information on use).

Side Effects

Rare cases of joint burning have been reported following Noltrex™ injection. All cases had mild or moderate pain intensity with an average duration of 12–24 hours. No pain symptoms lasted more than 3 days.

The pain syndrome is relieved by taking NSAIDs (the course is prescribed individually by the attending physician).

No hypersensitivity reactions to the material have been reported to date.

Interaction

It is possible to use Noltrex™ simultaneously with Diprospan, Traumeel-S or Zeel-T. It has not been studied in combination with other drugs and products.

It should not be mixed with other agents intended to restore the viscosity of synovial fluid.

It is possible to sequentially administer the material with a local anesthetic.

Storage conditions

At 1–30 °C

Shelf life

3 years.

Manufacturer

Bioform, Russia